BioStock: Chordate accelerates global market entry

Last week, the medtech company Chordate Medical announced two new agreements for the market introduction of the company’s migraine treatment in Germany and Israel. These are further signs that the global market establishment of the treatment is initiated, which CEO Anders Weilandt tells more about in an interview with BioStock.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/09/chordate-accelerates-global-market-entry/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se